Cardiovascular medications
2 papers2 findings
- Funders: National Institute on Aging and 1 more
- Humans1
Outcomes
1Mortality
downin silico1
1 study
Mortality
downin silico1
Cardiovascular medications decrease mortality in silico (60 vs 88 deaths).
“Markov simulation projected 132 ASCVD cases and 88 deaths over 5 years in this untreated cohort, compared to 93 ASCVD cases and 60 deaths with preventive therapy”
In silicountreated eligible adults5 yearsn = 1,083
AHA Scientific Sessions 2025 abstract3 Nov 2025
Associations
1Atherosclerotic cardiovascular disease
downin silico1
1 study
Atherosclerotic cardiovascular disease
downin silico1
Cardiovascular medications lower the risk of atherosclerotic cardiovascular disease in silico (93 vs 132 cases).
“Markov simulation projected 132 ASCVD cases and 88 deaths over 5 years in this untreated cohort, compared to 93 ASCVD cases and 60 deaths with preventive therapy”
In silicountreated eligible adults5 yearsn = 1,083
AHA Scientific Sessions 2025 abstract3 Nov 2025
Funding
3 grants since 2016National Institute on AgingUS$3mCanadian Institutes of Health Research (CIHR) Project GrantCA$100k
National Institute on AgingYale UniversityUS$243k2024–2029
National Institute on AgingPalo Alto Veterans Instit for ResearchUS$83.8k2019–2029
Canadian Institutes of Health Research (CIHR) Project GrantToronto Public HealthCA$100k2016–2017